United States, Aug. 22 -- The U.S. Food and Drug Administration began daily publication of adverse event data from the FDA Adverse Event Reporting System (FAERS). This represents a significant step forward in modernizing the agency's safety monitoring infrastructure and demonstrates its commitment to radical transparency and real-time protection of public health. FAERS is the FDA's primary database for collecting and analyzing adverse event reports, serious medication errors, and product quality complaints for prescription drugs and therapeutic biologics, containing reports submitted by healthcare professionals, consumers, and manufacturers.The shift is one of many steps in the FDA's broader data modernization strategy to streamline all of ...